{"data":[{"accessionNo":"0000897423-26-000125","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"Bass Edward P","reportingCik":null,"personType":"IN","sharesOwned":9385561,"percentOfClass":7.5,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000125","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"THRU LINE L.P.","reportingCik":null,"personType":"PN","sharesOwned":7876267,"percentOfClass":6.3,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"BRATTON DOUGLAS K","reportingCik":null,"personType":"IN","sharesOwned":691873,"percentOfClass":0.6,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"Bratton Capital Inc.","reportingCik":null,"personType":"CO","sharesOwned":391670,"percentOfClass":0.3,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"Bratton Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":390795,"percentOfClass":0.3,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"MonoLine RX II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"MonoLine RX, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"Bratton Family Partners L.P.","reportingCik":null,"personType":"PN","sharesOwned":33727,"percentOfClass":0,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"MonoSol Rx Genpar, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"MonoLine Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0000897423-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock, Par Value $0.001 Per Share","eventDate":"2026-10-07","reportingPerson":"MonoLine RX III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0002012383-26-002183","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001398733","issuerName":"AQUESTIVE THERAPEUTICS INC","ticker":"AQST","cusip":"03843E104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":7992647,"percentOfClass":6.4,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001493215-25-000037","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":6250000,"percentOfClass":5.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0001493215-25-000037","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001398733","issuerName":"Aquestive Therapeutics, Inc.","ticker":"AQST","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":6250000,"percentOfClass":5.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"},{"accessionNo":"0002012383-25-002498","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001398733","issuerName":"AQUESTIVE THERAPEUTICS INC","ticker":"AQST","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":6426343,"percentOfClass":5.3,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/aqst"}],"updatedAt":"2026-10-24T18:32:23.737Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/aqst","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}